Kairos Pharma KAPA
NYSE KAPA
$0.60 +0.02 (+2.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Market Capitalization (2024 - 2025)

Updated

Kairos Pharma's Market Capitalization came in at $103.48 million for Q4 2025, down 14.4% from $120.83 million a year earlier.

Analysis

Kairos Pharma (KAPA) Market Capitalization (2024 - 2025) Analysis & Trends

Going back to Q3 2024, Kairos Pharma's Market Capitalization data covers 5 quarters.

  • Going back by year, Market Capitalization was $120.83 million in FY2024.
  • The five-year range for quarterly Market Capitalization is $88.01 million (Q2 2025) to $141.19 million (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kairos Pharma 10.86 Mn -1.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 103.48 Mn
Jun 30, 2025 88.01 Mn
Mar 31, 2025 103.65 Mn
Dec 31, 2024 120.83 Mn
Sep 30, 2024 141.19 Mn
API Access

Kairos Pharma Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=KAPA&period=max&api_key=YOUR_API_KEY